LIN vs PSA · P/E 34, rev $33.99B vs rev $4.82B
Linde plc Ordinary Shares (LIN) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
PSA (PSA) common stock.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. PSA currently screens at market cap $0.
Not investment advice. Open the LIN and PSA stock pages for the full models.
Not investment advice.